INDP is trading approximately 6% down today at $2.68 following a sharp drop in the previous session and ongoing market uncertainty.
- No new company filings, press releases, or major headlines have been released by Indaptus Therapeutics to explain the current move.
- The decline appears to be driven by prior speculative trading and lingering concerns regarding the company's financing and strategic options rather than a fresh fundamental development.